A quaternary anti-cholinesterase probe for determining the integrity of the blood--brain barrier.
7-(Methylethoxyphosphinyloxy)-1-methyl quinolinium iodide (MEPQ), a new quaternary anti-cholinesterase (anti-ChE) compound was prepared and evaluated as a potential probe for assessing changes in the blood-brain barrier (B-BB) permeability. MEPQ was found to be 170 times more potent in its cholinesterase inhibitory activity than phospholine iodide, a previously reported anti-ChE probe in B-BB research. In rats and mice with impaired B-BB induced by osmotic opening, MEPQ readily penetrated through the damaged site as demonstrated by considerable reduction of ChE activity. In controls, brain ChE activity remained unaffected. It is suggested that MEPQ is a useful probe for both qualitative (histological staining) and quantitative (brain homogenated) assessment of permeability changes in the B-BB.
D000818:Animals; D001812:Blood-Brain Barrier / Q000187:drug effects; D002540:Cerebral Cortex / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D007031:Hypothalamus / Q000201:enzymology; D008297:Male; D051379:Mice; D010539:Permeability; D011806:Quinolinium Compounds / Q000494:pharmacology*; D051381:Rats
D002800:Cholinesterase Inhibitors; D011806:Quinolinium Compounds; C044294:7-((methylethoxyphosphinyl)oxy)-1-methylquinolinium